Kidney anemia pill study for kids pulled before it started
NCT ID NCT05082584
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to test a once-daily pill called vadadustat for treating anemia in children with chronic kidney disease. The goal was to see if the drug could safely raise red blood cell levels without the need for injections. However, the study was withdrawn before enrolling any participants, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA OF CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
Hackensack, New Jersey, 07601, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a pill tailored to inflammation boost red blood cells in kidney disease?
- New anemia drug for dialysis patients enters final testing phase
- Could a pill replace needles for anemia in dialysis?
- New hope for kidney patients: experimental anemia drug shows promise
- New anemia pill for dialysis patients tested against standard shots
- Kidney anemia pill for kids pulled before starting